61st Congress of European Renal Association, Stockholm, Sweden, 23 - 26 May 2024, pp.1487-1488
Background and Aims: Arterial stiffness affects almost all maintenance hemodialysis (MHD) patients and is one of the most important predictors of cardiovascular morbidity and mortality. Medium cut-off (MCO) membrane technology provides higher clearance of
large-middle uraemic toxin and cytokines compared to conventional dialyzers. In this case-control study, we investigated the change
in the arterial stiffness parameters after the transition to MCO dialyzers in MHD patients receiving treatment with low-flux dialyzers.
Method: We conducted a prospective, single-center cross-over study including 19 MHD patients receiving treatment with low-flux
dialyzers. Baseline and repeated parameters were measured from the brachial artery on a mid-week HD session at 0th, 120th, and
240th minutes, and the average of the three measurements were analyzed. The repeated parameters were measured two weeks after
the switching to MCO dialyzers which were decided by the clinician according to clinical indication.
Results: The median age was 71 (51, 79) years, and 57.9% of the patients were female. The frequency of diabetes was 36.8%, and
hypertension was 73.7%. 21.1% patients were smokers. 31.6% of the patients had a history of cardiovascular disease. Two weeks after
switching to MCO dialyzers, the Kt/Vs, urea reduction ratios, laboratory parameters, systolic, diastolic, and mean arterial pressures
remained similar to baseline. The mean pulse wave velocity was 10.3 m/s (8.4, 11.0) with low-flux dialyzers and 10.2 m/s (7.0, 11.5) with
MCO dialyzers (p = 0.38). The mean heart rate adjusted augmentation index [AIx(75)] was 20.0% (15.0, 30.3) with low-flux dialyzers
and 13.0% (11.0, 22.0) with MCO dialyzers (p = 0.04).
Conclusion: Our study showed that the rapid effect of MCO membranes is the reduction in peripheral wave reflections defined by
AIx(75). Additional long-term diseases are required to determine whether MCO dialyzers might improve the cardiovascular prognosis
of MHD patients